Generalized tetanus in adults without antitetanus booster vaccination in southern Mauritania

被引:0
|
作者
Boushab, Boushab Mohamed [1 ]
Fall-Malick, Fatim-Zahra [2 ]
Savadogo, Mamoudou [3 ]
Basco, Leonardo K. [4 ]
机构
[1] Kiffa Reg Hosp, Dept Internal Med & Infect Dis, Assaba, Mauritania
[2] Natl Inst Hepatitis & Virol, Sch Med, Nouakchott, Mauritania
[3] Univ Teaching Hosp Yalgado Ouedrago, Dept Infect Dis, Ouagadougou, Burkina Faso
[4] Aix Marseille Univ, Inst Hosp Univ Mediterranee Infect, Unite Mixte Rech Vecteurs Infect Trop & Mediterra, Inst Rech Dev,AP HM,Serv Sante Armees, Marseille, France
来源
CLINICAL CASE REPORTS | 2018年 / 6卷 / 05期
关键词
Clostridium tetani; Mauritania; tetanus; vaccination;
D O I
10.1002/ccr3.1470
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tetanus has become rare in countries with high levels of vaccination coverage and hygiene but may still occur in adults without booster vaccination. In addition to the expanded program on immunization for children and maternal immunization against neonatal tetanus, a systematic vaccination of the population, including boosters, is recommended.
引用
收藏
页码:835 / 838
页数:4
相关论文
共 50 条
  • [41] Economic impact of implementing decennial tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccination in adults in the United States
    Havers, Fiona P.
    Cho, Bo-Hyun
    Walker, Joseph W.
    Hariri, Susan
    VACCINE, 2020, 38 (02) : 380 - 387
  • [42] Tetanus Toxoid carrier protein induced T-helper cell responses upon vaccination of middle-aged adults
    van der Heiden, Marieke
    Duizendstra, Aafke
    Berbers, Guy A. M.
    Boots, Annemieke M. H.
    Buisman, Anne-Marie
    VACCINE, 2017, 35 (42) : 5581 - 5588
  • [43] Critical prevalence of antibodies minimizing vaccination costs for hepatitis A, hepatitis B, varicella, measles and tetanus in adults and adolescents in Catalonia, Spain
    Plans-Rubió, P
    VACCINE, 2004, 22 (29-30) : 4002 - 4013
  • [44] Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial
    Bonelli, Michael
    Mrak, Daniel
    Tobudic, Selma
    Sieghart, Daniela
    Koblischke, Maximilian
    Mandl, Peter
    Kornek, Barbara
    Simader, Elisabeth
    Radner, Helga
    Perkmann, Thomas
    Haslacher, Helmuth
    Mayer, Margareta
    Hofer, Philipp
    Redlich, Kurt
    Husar-Memmer, Emma
    Fritsch-Stork, Ruth
    Thalhammer, Renate
    Stiasny, Karin
    Winkler, Stefan
    Smolen, Josef S.
    Aberle, Judith H.
    Zeitlinger, Markus
    Heinz, Leonhard X.
    Aletaha, Daniel
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (05) : 687 - 694
  • [45] Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria-tetanus-toxoid vaccines
    Theeten, Heidi
    Ruemkeb, Hans
    Hoppener, Floris J. P.
    Vilatimo, Ramon
    Narejos, Silvia
    Van Damme, Pierre
    Hoet, Bernard
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (11) : 2729 - 2739
  • [46] Spotlight on Tdap5 Vaccine (Covaxis®) as a Single-Booster Immunization for the Prevention of Tetanus, Diphtheria, and PertussisIn Children (Aged ≥4 Years), Adolescents, and Adults
    Lesley J. Scott
    Pediatric Drugs, 2011, 13 : 133 - 135
  • [47] Immunogenicity and safety of a booster dose of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) in adolescents and adults: a Phase III randomized study
    Anez, German
    Hedrick, James
    Simon, Michael W.
    Christensen, Shane
    Jeanfreaue, Robert
    Yau, Eddy
    Pan, Judy
    Jordanov, Emilia
    Dhingra, Mandeep S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2020, 16 (06) : 1292 - 1298
  • [48] High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine
    McIntyre, PB
    Turnbull, FM
    Egan, AM
    Burgess, MA
    Wolter, JM
    Schuerman, LM
    VACCINE, 2004, 23 (03) : 380 - 385
  • [49] Tolerability of the biken acellular pertussis vaccine in adults with or without previous vaccination against pertussis in childhood
    Knuf, M
    Schmitt, HJ
    Mohnike, K
    Zepp, F
    Habermehl, P
    Kampmann, C
    Herden, P
    MEDIZINISCHE KLINIK, 2004, 99 (09) : 495 - 499
  • [50] Longitudinal determination of hepatitis B surface antigen-specific B lymphocyte frequency in healthy high responder adults after booster vaccination
    Sam, Mohammad Reza
    Shokrgozar, Mohammad Ali
    Shokri, Fazel
    INTERVIROLOGY, 2008, 51 (02) : 87 - 95